Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients

被引：0

作者：

Mustafa, Shokhan Mohammad ^{[1
]}

Yassin, Ahmed Khudair ^{[2
]}

Mohammed, Nawsherwan S. ^{[2
]}

Shamoon, Rawand P. ^{[2
]}

Karma, Marwa N. ^{[1
]}

Mohammad, Shlan S. ^{[1
]}

Abdulrahman, Lara Lateef ^{[1
]}

Ahmed, Zhalla O. ^{[1
]}

Rashid, Bryar Sabah ^{[1
]}

Mahmood, Tavan I. ^{[1
]}

Yousif, Rozhhat A. ^{[1
]}

Hasan, Kawa M. ^{[2
]}

Mohamed, Zaki A. ^{[2
]}

Getta, Hisham A. ^{[1
]}

Jalal, Sana D. ^{[2
]}

Abdullah, Dana A. ^{[2
]}

Abdulla, Basil K. ^{[1
]}

Numan, Ghanim S. ^{[1
]}

Karadagh, Ranan ^{[2
]}

机构：

[1] Minist Hlth, Erbil, Iraq

[2] Minist Higher Educ, Erbil, Iraq

来源：

关键词：

CLL; rituximab; chronic lymphocytic leukemia; complete response; cyclophosphamide; fludarabine; survival;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CLL-035

引用

页码：S260 / S261

页数：2